Back to search

Inhibitory effect of azelastine hydrochloride on synthesis and release of platelet activating factor from human alveolar macrophages

Data up to Jan 2025

Published1997
Citations4
References28

Total Citations Per Year

Abstract

References (28)

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

1959 • 47,127 citations

Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease

1995 • 3,549 citations

Statement on Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease (COPD) and Asthma

1987 • 2,165 citations

Platelet-activating factor.

1990 • 904 citations

Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.

1986 • 596 citations

The alveolar macrophage

1986 • 509 citations

Physicochemical and Functional Identity of Rabbit Platelet-Activating Factor (PAF) Released in Vivo during IgE Anaphylaxis with PAF Released in Vitro from IgE Sensitized Basophils

1979 • 454 citations

Increased biosynthesis of platelet-activating factor in activated human eosinophils.

1984 • 423 citations

Enzymatic synthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine, a hypotensive and platelet-aggregating lipid.

1980 • 321 citations

Involvement of immunoglobulin E in the secretory processes of alveolar macrophages from asthmatic patients.

1983 • 241 citations

Biosynthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor and a hypotensive lipid) by cholinephosphotransferase in various rat tissues

1981 • 200 citations

The effect of the orally active platelet-activating factor antagonist WEB 2086 in the treatment of asthma.

1994 • 96 citations

Arachidonic Acid Metabolism in Cultured Alveolar Macrophages from Normal, Atopic, and Asthmatic Subjects

1988 • 85 citations

Anti-allergic effect of azelastine hydrochloride on immediate type hypersensitivity reactions in vivo and in vitro.

1981 • 79 citations

Pharmacological and toxicological properties of azelastine, a novel antiallergic agent.

1981 • 74 citations

Platelet-activating factor in bronchoalveolar lavage fluid from asthmatic subjects

1990 • 72 citations

Characterization of Fc receptors for IgE on human alveolar macrophages.

1982 • 64 citations

Platelet‐Activating Factor Isolation, Identification, and Assay

1985 • 59 citations

Inhibition by azelastine of nonallergic histamine release from rat peritoneal mast cells

1984 • 58 citations

Immunoglobulin E-dependent stimulation of human alveolar macrophages: significance in type 1 hypersensitivity.

1986 • 56 citations

Inhibition of Allergic Histamine Release by Azelastine and Selected Antiallergic Drugs from Rabbit Leukocytes

1985 • 55 citations

Azelastine, a New Antiallergic/Antiasthmatic Agent, Inhibits PAF-Acether-Induced Platelet Aggregation, Paw Edema and Bronchoconstriction

1988 • 35 citations

241 Inhibition of leukotriene (SRS-A)-mediated allergic bronchospasm by azelastine, a novel orally effective antiasthmatic drug

1983 • 26 citations

Priming effect of platelet activating factor on leukotriene C4 from stimulated eosinophils of asthmatic patients.

1996 • 18 citations

Platelet-activating Factor in Bronchoalveolar Lavage from Patients with Sarcoidosis

1992 • 16 citations

Azelastine hydrochloride inhibits platelet activating factor-like activity in human eosinophils

1996 • 7 citations

Effect of azelastine hydrochloride on release and production of platelet activating factor in human neutrophils

1997 • 6 citations

Release of platelet-activating factor from stimulated asthmatic eosinophils

1996 • 2 citations

Cited By (0)

Loading...
Inhibitory effect of azelastine hydrochloride on synthesis and release of platelet… (1997) – Prostaglandins Leukotrienes and Essential Fatty Acids | Metascience Observatory Explorer